# Key Studies

## Critical Care
### Renal replacement therapy
- AKIKI (standard vs delayed RRT)
- AKIKI-2 (delayed vs more-delayed RRT)
- STARRT-AKI (early vs standard RRT)

### Fluids
- SALT-ED (balanced vs saline in ED)
- SMART (balanced vs saline in ICU)
- BaSICS (balanced vs saline and slow vs fast bolus in ICU)
- SAFE (saline vs albumin in ICU)

### Mechanical ventilation and ARDS
- ACURASYS (cisatracurium in early ARDS)
- ROSE (cisatrcurium in early ARDS with modern sedation practices)
- PROSEVA (early proning in ARDS)
- ARDSNet (low VT and plateau pressure guided ventilation strategy -- "low-stretch")

### Sepsis and septic shock
- Rivers et al. 2001 (early goal directed therapy for septic shock)
- ProCESS (validation trial)
- ARISE (validation trial)
- ProMISE (validation trial)

## Nephrology
### Chronic kidney disease
- SHARP (statin and ezetimibe in CKD)
- DAPA-CKD
- CANVAS

### Hypertension
- SPRINT (intensive BP control in higher risk patients)
- ACCORD-BP
- SHEP
- ACCOMPLISH

### Nephritis
- PEXIVAS
- MEPEX
- TESTING (steroids in IgA nephropathy)

## Cardiology
### Heart Failure
#### SGLT2 inhibitors in heart failure
- EMPEROR-Preserved
- DAPA-HF

#### Beta blockers in heart failure
- MERIT-HF (metoprolol)
- CIBIS-II (bisoprolol)
- US Carvedilol HF Study

#### MRAs in heart failure
- TOPCAT (spironolactone in HFpEF)

#### RAS inhibition in heart failure
- PARADIGM-HF
- PARAGON-HF

#### Other heart failure medications
- VICTORIA
- GALACTIC-HF
- DIG

### Acute coronary syndrome
- PARADISE-MI
- DINAMIT
- IRIS
- CABG-Patch
- IMPROVE-IT
- PLATO
- PEGASUS-TIMI 54
- DAPT
- CURE

### Chronic coronary syndrome
- COMPASS (low dose rivaroxaban for stable vascular disease)
- SCOT-HEART (CCTA)
- PROMISE (CCTA)

### Atrial fibrillation
- RATE-AF
- EAST-AFNET 4
- EARLY-AF
- RACE II
- AFFIRM
- LAAOS III

### AF and PCI
- AUGUSTUS
- ENTRUST-AF PCI
- RE-DUAL
- PIONEER-AF PCI

### PCI and CABG
- EXCEL
- FREEDOM
- COMPLETE

## Thrombosis
- BRIDGE
- PAUSE
